Photo from Caryn Lerman / Linkedin
Aug 9, 2023, 18:36
Evanthia Roussos Torres recently was awarded R01 funding from the National Cancer Institute to investigate how targeting myeloid suppression enhances anti-tumor immunity in breast cancer – Caryn Lerman
Congratulations to Dr. Evanthia Roussos Torres, member of the USC Norris Tumor Immunology & Microenvironment Program, who recently was awarded R01 funding from the National Cancer Institute to investigate how targeting myeloid suppression enhances anti-tumor immunity in breast cancer. Her work will reveal how epigenetic modulation of myeloid suppression in breast cancers can improve response to checkpoint inhibition, and, along with collaborators she will incorporate mathematical modeling that will decipher the complex and collective mechanisms of altered suppression, as well as predict tumor response to novel therapies.
Source: Caryn Lerman / Linkedin
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 1, 2025, 19:09
Apr 1, 2025, 18:48
Apr 1, 2025, 18:37
Apr 1, 2025, 18:26
Apr 1, 2025, 18:22